Medscape is available in 5 Language Editions – Choose your Edition here.


Rickettsial Infection

  • Author: Mobeen H Rathore, MD, CPE, FAAP, FIDSA; Chief Editor: Russell W Steele, MD  more...
Updated: Jun 14, 2016


Rickettsiae comprise a group of microorganisms that phylogenetically occupy a position between bacteria and viruses. The genus Rickettsia is included in the bacterial tribe Rickettsiae, family Rickettsiaceae, and order Rickettsiales. They are obligate intracellular gram-negative coccobacillary forms that multiply within eukaryotic cells. Rickettsiae do not stain well with Gram stain, but they take on a characteristic red color when stained by the Giemsa or Gimenez stain. They have typical gram-negative cell walls and lack flagella. Their genome is very small, composed of 1-1.5 million bases.[1, 2]

Rickettsiae are a rather diverse collection of organisms with several differences; this prohibits their description as a single homogenous group. A general characteristic of rickettsiae is that mammals and arthropods are natural hosts. Rickettsioses are usually transmitted to humans by arthropods. Q fever, traditionally described among the rickettsial illnesses until recently, is primarily acquired by inhalation of contaminated airborne droplets.[3, 4, 5]

The epidemiology of human diseases caused by rickettsiae is intimately related to the biology of the vector that transmits it. Rickettsial diseases widely vary in severity from self-limited mild illnesses to fulminating life-threatening infections.[4]

Rickettsial illnesses, caused by organisms within the genus of rickettsiae, are recognized and can be divided into the following 3 biogroups:[2, 6]

Spotted fever biogroup (15 rickettsioses)

See the list below:

  • Rocky Mountain spotted fever (RMSF), caused by Rickettsia rickettsii
  • Rickettsialpox, caused by Rickettsia akari
  • Boutonneuse fever (ie, Kenya tick-bite fever, African tick typhus, Mediterranean spotted fever, Israeli spotted fever, Indian tick typhus, Marseilles fever)

Typhus group

These are similar diseases that differ epidemiologically. The causative organisms (Rickettsia prowazekii and Rickettsia typhi) are similar to those of the spotted fever group but are antigenically distinct.

  • Louse-borne (epidemic) typhus
  • Brill-Zinsser disease (ie, relapsing louse-borne typhus)
  • Murine (endemic or flea-borne) typhus

Scrub typhus biogroup (Tsutsugamushi disease)

The rickettsial agents of scrub typhus have a single taxonomic name: Orientia tsutsugamushi. However, these organisms represent a heterogeneous group that strikingly differs from Rickettsial species of the spotted fever and typhus groups. The 3 major serotypes are Karp, Gilliam, and Kato.

Other rickettsioses and closely related illnesses

See the list below:

  • New or reemerging rickettsioses have been described in the last few decades, including tickborne lymphadenopathy (TIBOLA) and Dermacentor -borne-necrosis-eschar-lymphadenopathy (DEBONEL) related to Rickettsia slovaca infection, as well as lymphangitis-associated rickettsiosis attributed to Rickettsia sibricia infection. [1] Recently, a new Rickettsia species, 364D, that causes an eschar-associated illness was identified in California. [7, 8]
  • Ehrlichia organisms (the cause of human monocytic ehrlichiosis and Ehrlichia ewingii infection), Anaplasma phagocytophilum (the cause of human granulocytic anaplasmosis), and Bartonella species (the cause of Catscratch disease, relapsing fever, and Trench fever) are organisms related to the rickettsiae. They are discussed in separate articles.
  • Q fever is a disease caused by Coxiella burnetii, which has recently been removed from the Rickettsiales. [5] The disease is described here for comparison with other rickettsioses.

The environmental stability, small size, aerosol transmission, persistence in infected hosts, low infectious dose and high associated morbidity and mortality have made pathogenic rickettsiae desirable bioterrorism agents. In fact, R prowazekii and C burnetii have been weaponized. However, developing rickettsial pathogens as biological weapons has many drawbacks, such as the lack of direct host-to-host transmission and availability of therapeutic countermeasures against them.[9]



Rickettsiae microorganisms appear to exert their pathologic effects by adhering to and then invading the endothelial lining of the vasculature within the various organs affected. The adhesins appear to be outer membrane proteins that allow the rickettsia to be phagocytosed into the host cell. Once inside, the rickettsial organisms either multiply and accumulate in large numbers before lysing the host cell (typhus group) or they escape from the cell, damaging its membrane and causing the influx of water (spotted fever group).[4]

Rickettsiae rely on the cytosol of the host cells for growth. To avoid phagocytosis within the cells, they secrete phospholipase D and hemolysin C, which disrupt the phagosomal membrane, allowing for rapid escape.

The most important pathophysiologic effect is increased vascular permeability with consequent edema, loss of blood volume, hypoalbuminemia, decreased osmotic pressure, and hypotension. On the other hand, disseminated intravascular coagulation is rare and does not seem to contribute to the pathophysiology of rickettsiae.

Studies of murine models have demonstrated that rickettsiae are cleared by cytotoxic CD8 cells and by cytokine-activated rickettsicidal nitrogen and oxygen species. In fact, antibodies do not play an important role in immunity against pathogenic rickettsia upon fist exposure. Walker provided an excellent review of this topic.[1]

  • RMSF: In RMSF, rickettsiae multiply within the endothelial cells of small blood vessels and then gain access to the bloodstream after skin inoculation. Focal areas of endothelial proliferation and perivascular mononuclear cell infiltration cause leakage of intravascular fluid into tissue space. These vascular lesions can affect all organs; however, they most readily are found in the skin and adrenals. In the central nervous system and heart, a damaging host response (primarily cell-mediated) accompanies the vasculitis. The liver is usually affected with portal triaditis. Vascular wall destruction consumes platelets, causing thrombocytopenia. Multiple factors lead to hypoalbuminemia (eg, renal loss, decreased intake, hepatic involvement) and hyponatremia (eg, renal loss, extracellular fluid shifts, cellular exchange of sodium for potassium).
  • Rickettsialpox: The organism that causes this illness is known to cause angiitis similar to other rickettsiae. Biopsies, which are rarely needed to establish the diagnosis of rickettsialpox, show evidence of thrombosis and necrosis of capillaries, as well as perivascular mononuclear cell infiltration.
  • Boutonneuse fever: Features of this illness are related to involvement of the vascular structures of the dermis in a manner similar to that observed in RMSF. Endothelial cells of the capillaries, venules, and arterioles (ie, small-to-medium sized vessels) in various organs may also become involved as the organism disseminates. [10] Additionally, a few cases of leukocytoclastic vasculitis have been reported with this infection.
  • Louse-borne (epidemic) typhus: The pathology is similar to that described for the spotted fever group of rickettsial diseases. However, typhus group rickettsiae do not stimulate actin-based mobility and rather extensively multiply and accumulate intracellularly until they burst the endothelial cell and disseminate into the bloodstream.
  • Brill-Zinsser disease (ie, relapsing louse-borne typhus): The pathology is similar to that described for the spotted fever group of rickettsial diseases. However, the organisms appear to lie dormant, most likely in the cells of the reticuloendothelial system, until they are reactivated by an unknown stressor, multiply and cause another acute but milder infection.
  • Murine (endemic or flea-borne) typhus: Pathology is similar to that described for epidemic typhus.
  • Tsutsugamushi disease (ie, scrub typhus): After invading the host cell and replicating in its cytoplasm, the Orientia tsutsugamushi exits by budding enveloped by part of the host cell membrane as it invades adjacent cells. Perivasculitis of small blood vessels occurs similarly to other rickettsial diseases. Usually, a necrotic inflammatory skin lesion occurs at the mite bite site, and regional and generalized lymphadenopathy is associated with this infection.
  • Q fever: In Q fever, the Coxiella organism directly causes disease in various organs. It has been demonstrated in macrophages in the lungs and in vegetations of the heart valves. Host-mediated pathogenic mechanisms also appear to play an important role in disease pathogenesis; the disease causes granulomatous changes in reticuloendothelial organs (granulomatous hepatitis).



United States


RMSF is caused by R rickettsii. Now reported in all geographic areas of the United States, RMSF was first recognized in and thought to be limited to the Rocky Mountain area. Its incidence sharply declined with the introduction of broad-spectrum antibiotics in the 1950s; the incidence soared again in the 1960s and peaked in 1981. Incidence has declined since that time. The average annual incidence from 1997-2002, based on passive surveillance, was 2.2 cases per million population. Incidence increased from 1.7 cases per million person-years in 2000 to 14.3 cases per million person-years in 2012.[11]   The major endemic areas in the United States today include North Carolina, Oklahoma, South Carolina, Tennessee and Arkansas. More than 90% of patients with RMSF are infected from April through September. Individuals with frequent exposure to dogs and who reside near wooded areas or areas with high grass are at an increased risk of infection.[3, 12, 13]


In the United States, rickettsialpox most commonly occurs in the Northeast, especially in New York city. Despite sporadic periodic outbreaks, incidence appears to be declining. The natural host is the common house mouse (Mus musculus).

Boutonneuse fever

This disease is very rare outside a limited geographical area in the Mediterranean, Africa, and India. With increased travel and ecotourism in endemic areas, more imported cases of the disease are described in travelers returning to the United States from Mediterranean regions.[10]

Louse-borne (epidemic) typhus

This is rare in the United States, but sporadic cases have been reported. The presumed source of infection is the southern flying squirrel.

Brill-Zinsser disease (ie, relapsing louse-borne typhus)

The distribution of this disease is analogous to louse-borne epidemic typhus. Recently, it has been rarely reported in the United States, and all cases had acquired the primary infection elsewhere.[14, 2, 15]

Endemic murine (flea-borne) typhus

This type of typhus is prevalent in urban cities and costal ports where rats are abundant. This is because it is transmitted rat-to-rat by a rat flea (Xenopsylla cheopis) and transmitted accidentally to humans by the feces of infected fleas. The cat flea (Ctenocephalides felis) may also serve as a vector for transmission of this disease to humans. These may be important vectors in Texas and southern California. Incidence has declined coincident with increased use of insecticides. Cases occur throughout the year, with peak prevalence from April through June in Texas and during the warm months of summer and early fall elsewhere.[14, 16]

Tsutsugamushi disease (ie, scrub typhus)

This is extremely rare outside the southwest Pacific and Southeast Asia.[17]

Q fever

Outbreaks are most common in slaughterhouses, research facilities, and plants, where handling of animals or their birth products is a source of exposure. Prevalence of Q fever in the United States is underestimated. Since Q fever became a nationally reportable disease in 1999 in the United States, a linear increase has been observed in the number of human cases identified (17 cases with onset in 2000 compared with 167 cases with onset in 2007). The incidence of Q fever increased similarly, from less than 0.1 case per million persons in 2000 to 0.6 case per million persons in 2007.

The surveillance case definition for Q fever was modified in 2008 to revise laboratory criteria for diagnosis and to allow for the separate reporting of acute and chronic Q fever. During 2008–2010, the number of reported cases decreased slightly, relative to 2007, and the incidence rate has decreased to 0.4 case per million persons. One hundred thirty-one cases of Q fever were reported with onset in 2010; of these, 106 were acute Q fever and 25 were chronic Q fever.[18]


The spotted fever rickettsiae have been found in every continent except Antarctica.[2]

  • RMSF: This primarily occurs in the continental United States but has been reported in southern Canada, Central America, Mexico, and parts of South America. It is rarely seen elsewhere. [12]
  • Rickettsialpox: This may be more prevalent worldwide than is reported. It has been identified in large cities in Russia, South Africa, and Korea.
  • Boutonneuse fever has demonstrated an increased incidence in Mediterranean countries, such as Spain, Italy, and Israel. Along with African tick–bite fever, these infections have been identified in Algeria, Malta, Cyprus, Slovenia, Croatia, Kenya, Somalia, South Africa, Ethiopia, India, and Pakistan, as well as rural Sub-Saharan Africa, the eastern Caribbean, and around the Black Sea. [4, 10]
  • Louse-borne (epidemic) typhus: Epidemics have occurred in Europe, Asia, and Africa. African countries, especially Ethiopia and Nigeria, have reported most of the cases in the last 2 decades.
  • Brill-Zinsser disease (ie, relapsing louse-borne typhus): This disease follows the epidemiology of louse-borne epidemic typhus and rarely, if ever, occurs in children because the reactivation usually occurs decades after primary infection.
  • Murine (endemic or flea-borne) typhus: This is prevalent in large cities around the world where rats abound. It has been reported in travelers returning from ports and beach resorts in Asia, Africa and Europe. [2, 17] Human infections with rickettsia contracted after exposure to cat fleas was recently described in Australia. The fleas involved demonstrated the presense of R felis. [19]
  • Tsutsugamushi disease (ie, scrub typhus): Cases are usually seen in rural south and southeast Asia, limited to the geographical area bound by Japan, the Solomon Islands, and Pakistan. It is estimated that 1 million cases occur each year.
  • Q fever: This zoonotic disease is observed in humans who come in contact with infected animals in Australia and Canada, as well as other areas of the world. Incidence figures widely vary. [5]


Rickettsial diseases vary in clinical severity according to the virulence of the Rickettsia and host factors, such as age, male gender, and other underlying diseases. The most virulent rickettsiae are R rickettsii and R prowazekii, which kill a significant portion of infected persons unless the diseases are sufficiently treated early with an effective antimicrobial agent.[4, 9]

  • RMSF: The overall mortality rate is 4%, despite effective antibiotic therapy. This most likely is caused by delay in the diagnosis and initiation of proper treatment. Patients treated during the first week of illness have the highest chance of complete recovery; however, if the disease is allowed to progress to the second week untreated, even optimal therapy progressively becomes less effective. [20] Deficiency of glucose-6-phosphate dehydrogenase (G-6-PD) enzyme is associated with a high proportion of severe cases of RMSF. This is a rare clinical course that is often fatal within 5 days of onset of illness.
  • Rickettsialpox: No mortality has occurred from this infection. Morbidity is minimal, as noted in Clinical.
  • Boutonneuse fever: This infection generally runs a benign course. Unusual presentations (eg, acute pancreatitis) [21] , rare complications (eg, hemophagocytic lymphohistiocytosis), [22] and severe forms of the disease have been described and fatalities are rare. [10]
  • Louse-borne (epidemic) typhus: Mortality rates in untreated cases correlate with the patient's age. The mortality rate is approximately 10% in young adults but approaches 60-70% in patients older than 50 years.
  • Brill-Zinsser disease (ie, relapsing louse-borne typhus): These relapses tend to be milder, shorter, and less debilitating.
  • Murine (endemic or flea-borne) typhus: Complications and mortality (1% mortality rate in the United States) are uncommon.
  • Tsutsugamushi disease (ie, scrub typhus): The illness usually is mild and self-limited. However, if left without treatment complications may include pneumonitis, meningoencephalitis, disseminated intravascular coagulation and renal failure. Fatality rate ranges from 1-35%, depending on the virulence of the infecting strain, host factors, and institution of proper treatment.
  • Q fever: Uncomplicated disease is self-limited, lasting for 10-90 days. Complications requiring hospitalization are rare and may include endocarditis, encephalitis, pneumonia, hepatitis, and splenomegaly. Rates of hospitalization among Q fever cases reported to the US Centers for Disease Control and Prevention (CDC) averaged over 50% during 2002-2008. However, it is likely that mild Q fever infections, which do not require hospitalization, may be more likely to be under-recognized and therefore under-represented in current national surveillance systems. [18] The overall mortality rate of Q fever is approximately 1%. However, the rate may increase to 30-60% with complications. [5]


No specific racial predilection is observed.


Males appear to be at higher risk for infection with tick-borne rickettsioses.[11] This is likely because of greater recreational or occupational exposures to tick habitats. However, in some spotted fever illnesses (eg, Q fever), females seem to be less susceptible to the infection possibly due to a protective role of female hormones.[10]


See the list below:

  • Two thirds of patients with RMSF are aged 15 years or younger. [4]
  • Rickettsialpox, boutonneuse fever, epidemic and endemic typhus, and Tsutsugamushi disease affect all ages.
  • Q fever occurs in all age group but is more prevalent between age 30-70 years. [5]
Contributor Information and Disclosures

Mobeen H Rathore, MD, CPE, FAAP, FIDSA Chief of Division of Pediatric Infectious Diseases/Immunology, Associate Chairman of Department of Pediatrics, University of Florida College of Medicine at Jacksonville; Hospital Epidemiologist and Section Chief of Infectious Disease and Immunology, Wolfson Children's Hospital; Director of University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES)

Mobeen H Rathore, MD, CPE, FAAP, FIDSA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Florida Medical Association, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Healthcare Epidemiology of America, Society for Pediatric Research, Southern Medical Association, Southern Society for Pediatric Research, Florida Chapter of The American Academy of Pediatrics, Florida Pediatric Society, European Society for Paediatric Infectious Diseases

Disclosure: Nothing to disclose.


Nizar F Maraqa, MD, FAAP Associate Professor of Pediatrics, Fellowship Program Director, Division of Pediatric Infectious Diseases and Immunology, University of Florida College of Medicine at Jacksonville

Nizar F Maraqa, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Reviewer for: MedStudy Corporation.

Saran A Wells, MD Fellow in Pediatric Infectious Disease, University of Florida College of Medicine at Jacksonville

Saran A Wells, MD is a member of the following medical societies: American Academy of Pediatrics, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Larry I Lutwick, MD Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

José Rafael Romero, MD Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center

José Rafael Romero, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, New York Academy of Sciences, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

  1. Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis. 2007 Jul 15. 45 Suppl 1:S39-44. [Medline].

  2. Jensenius M, Fournier P, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis. 2004. 34(10):1493-9. [Medline].

  3. Center of Disease Control and Prevention (CDC). Rickettsial Diseases. Infectious Disease Information. Available at

  4. Edwards MS, Feigin RD. Rickettsial diseases. Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. 5th ed. WB Saunders Co; 2004. 2497-2515/Chapter 195.

  5. Tissot-Dupont H, Raoult D. Q Fever. Infect Dis Clin N Am. Sept 2008. 22:505-514. [Medline].

  6. Walker DH. Rickettsiae. Baron S, ed. Medical Microbiology. 4th ed. University of Texas Medical Branch; 1996. [Full Text].

  7. Shapiro MR, Fritz CL, Tait K, Paddock CD, Nicholson WL, Abramowicz KF, et al. Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis. 2010 Feb 15. 50(4):541-8. [Medline].

  8. Johnston SH, Glaser CA, Padgett K, Wadford DA, Espinosa A, Espinosa N, et al. Rickettsia spp. 364D causing a cluster of eschar-associated illness, California. Pediatr Infect Dis J. 2013 Sep. 32 (9):1036-9. [Medline].

  9. Azad AF. Pathogenic Rickettsiae as Bioterrorism Agents. Clin Infect Dis. 2007 Jul 15. 45 Suppl 1:S52-55. [Medline].

  10. Rovery C, Raoult D. Meditteranean Spotted Fever. Infect Dis Clin N Am. Sept 2008. 22:515-530. [Medline].

  11. Drexler NA, Dahlgren FS, Heitman KN, Massung RF, Paddock CD, Behravesh CB. National Surveillance of Spotted Fever Group Rickettsioses in the United States, 2008-2012. Am J Trop Med Hyg. 2015 Aug 31. [Medline].

  12. Dumler JS, Walker DH. Rocky Mountain spotted fever--changing ecology and persisting virulence. N Engl J Med. 2005 Aug 11. 353(6):551-3. [Medline].

  13. Graf PC, Chertien JP, Ung L, et al. Prevalence of serpositivity to spotted fever group rickettsiae and Anaplasma phagocytophilum in a large, dempgraphically diverse US sample. Clin Infect Dis. Jan 2008. 46 (1):70-77. [Medline].

  14. Cowan G. Rickettsial diseases: the typhus group of fevers--a review. Postgrad Med J. 2000 May. 76(895):269-72. [Medline].

  15. Marshall GS. Rickettsia typhi seroprevalence among children in the Southeast United States. Tick-Borne Infections in Children Study (TICKS) Group. Pediatr Infect Dis J. 2000 Nov. 19(11):1103-4. [Medline].

  16. Fergie JE, Purcell K, Wanat D. Murine Typhus in South Texas children. Pediatr Infect Dis J. 2000. 19(6):535-38. [Medline].

  17. Aung AK, Spelman DW, Murray RJ, Graves S. Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers. Am J Trop Med Hyg. 2014 Sep. 91 (3):451-60. [Medline]. [Full Text].

  18. Centers for Disease Control and Prevention. Q Fever- Statistics and Epidemiology. Centers for Disease Control and Prevention. Available at Accessed: 02/23/2013.

  19. Williams M, Izzard L, Graves SR, et al. First probable Australian cases of human infection with Rickettsia felis (cat-flea typhus). Med J Aust. Jan 2011. 194(1):41-43. [Medline].

  20. Walker DH, Dumler JS. Emerging and reemerging rickettsial diseases. N Engl J Med. 1994 Dec 15. 331(24):1651-2. [Medline].

  21. Rombola F. Mediterranean spotted fever presenting as an acute pancreatitis. Acta Gastroenterol Belg. Mar 2011. 74(1):91-92. [Medline].

  22. Cascio A, Giordano S, Dones P, et al. Haemophagocytic syndrome and rickettsial diseases. J Med Microbiol. Apr 2011. 60(4):537-542. [Medline].

  23. Abramson JS, Givner LB. Rocky Mountain spotted fever. Pediatr Infect Dis J. 1999 Jun. 18(6):539-40. [Medline].

  24. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res. May-Jun 2005. 36:469-492. [Medline].

  25. Ruiz-Contreras J, Gonzalez Montero R, Ramos Amador JT, et al. Q fever in children. Am J Dis Child. 1993 Mar. 147(3):300-2. [Medline].

  26. Nourse C, Allworth A, Jones A, et al. Three cases of Q fever osteomyelitis in children and a review of the literature. Clin Infect Dis. 2004 Oct 1. 39(7):e61-6. [Medline].

  27. Sexton DJ, Corey GR. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis. 1992 Sep. 15(3):439-48. [Medline].

  28. Demma LJ, Traeger MS, Nicholson et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med. 2005 Aug 11. 353(6):587-94. [Medline].

  29. Nicholson WL, Allen KE, McQuiston JH, et al. The increasing recognition of rickettsial pathogens in dogs and people. Trends Parasitol. Apr 2010. 26(4):205-212. [Medline].

  30. Hildebrandt A, Franke J, Meier F, et al. The potential role of migratory birds in transmission cycles of Babesia spp., Anaplasma phagocytophilum, and Rickettsia spp. Ticks Tick Borne Dis. Jun 2010. 1(2):105-107. [Medline].

  31. Raoult D, Paddock CD. Rickettsia parkeri infection and other spotted fevers in the United States. N Eng J Med. 2005. 353:626-7. [Medline].

  32. Bechah Y, Socolovschi C, Raoult D. Identification of Rickettsial Infections by Using Cutaneous Swab Specimens and PCR. Emerg Infect Dis. Jan 2011. 17(1):83-86.

  33. Angelakis E, Richet H, Rolain JM, La Scola B, Raoult D. Comparison of real-time quantitative PCR and culture for the diagnosis of emerging Rickettsioses. PLoS Negl Trop Dis. 2012. 6(3):e1540. [Medline].

  34. Giulieri S, Jaton K, Cometta A, Trellu LT, Greub G. Development of a duplex real-time PCR for the detection of Rickettsia spp. and typhus group rickettsia in clinical samples. FEMS Immunol Med Microbiol. 2012 Feb. 64(1):92-7. [Medline].

  35. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother. 1991 Dec. 35(12):2457-62. [Medline].

  36. Purvis JJ, Edwards MS. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J. 2000 Sep. 19(9):871-4. [Medline].

  37. Kim CO, Huh AJ, Yeom JS, Lee KS, Chin BS, Han SH. Lack of effect of dexamethasone on growth of Orientia tsutsugamushi Gilliam in mouse L929 cells. Yonsei Med J. 2011 Jul. 52(4):624-9. [Medline].

  38. Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13. 65 (2):1-44. [Medline].

  39. Richards AL. Rickettsial Vaccines: the old and the new. Expert Rev Vaccines. October 2004. 3:541-555. [Medline].

  40. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006 Mar 31. 55(RR-4):1-27. [Medline].

  41. Fournier PE, Gouriet F, Brouqui P. Lymphangitis-associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases and review of the literature. Clin Infect Dis. 2005 May 15. 40(10):1435-44. [Medline].

  42. Jensenius M, Fournier P, Kelly P. African tick bite fever. Lancet Infect Dis. 2003. 3(9):557-64. [Medline].

  43. Spach DH, Liles WC, Campbell GL, et al. Tick-borne diseases in the United States. N Engl J Med. 1993 Sep 23. 329(13):936-47. [Medline].

This photo shows the relative sizes of the adult forms of Ixodes scapularis (right) and Dermacentor variabilis (left). These ticks are shown next to a common match for scale. I scapularis is also referred to as Ixodes dammini. Photo by Darlyne Murawski; reproduced with permission.
This photo is of an adult female, Amblyomma americanum, and a nymphal form of the same species (shown next to a common match for scale). Photo by Darlyne Murawski; reproduced with permission.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.